Adderall one of many drugs, medical supplies at risk
Resilinc
NOVEMBER 22, 2022
In October, the FDA announced a shortage of ADHD drug Adderall, with leading manufacturer Teva Pharmaceuticals forecasting that its generic brands would be in short supply until March 2023. Premier, for example, has worked with partners and even competitors over the last two years to increase domestic production and sourcing of PPE and APIs.
Let's personalize your content